These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

610 related articles for article (PubMed ID: 33023066)

  • 1. Neuroprotective Effect of Curcumin on the Nigrostriatal Pathway in a 6-Hydroxydopmine-Induced Rat Model of Parkinson's Disease is Mediated by α7-Nicotinic Receptors.
    El Nebrisi E; Javed H; Ojha SK; Oz M; Shehab S
    Int J Mol Sci; 2020 Oct; 21(19):. PubMed ID: 33023066
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Wnt/β-catenin signaling plays an essential role in α7 nicotinic receptor-mediated neuroprotection of dopaminergic neurons in a mouse Parkinson's disease model.
    Liu Y; Hao S; Yang B; Fan Y; Qin X; Chen Y; Hu J
    Biochem Pharmacol; 2017 Sep; 140():115-123. PubMed ID: 28551099
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 3-[(2,4-Dimethoxy)benzylidene]-anabaseine dihydrochloride protects against 6-hydroxydopamine-induced parkinsonian neurodegeneration through α7 nicotinic acetylcholine receptor stimulation in rats.
    Suzuki S; Kawamata J; Matsushita T; Matsumura A; Hisahara S; Takata K; Kitamura Y; Kem W; Shimohama S
    J Neurosci Res; 2013 Mar; 91(3):462-71. PubMed ID: 23239187
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Curcumin protects nigral dopaminergic neurons by iron-chelation in the 6-hydroxydopamine rat model of Parkinson's disease.
    Du XX; Xu HM; Jiang H; Song N; Wang J; Xie JX
    Neurosci Bull; 2012 Jun; 28(3):253-8. PubMed ID: 22622825
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dopaminergic neuroprotection and regeneration by neurturin assessed by using behavioral, biochemical and histochemical measurements in a model of progressive Parkinson's disease.
    Oiwa Y; Yoshimura R; Nakai K; Itakura T
    Brain Res; 2002 Aug; 947(2):271-83. PubMed ID: 12176170
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fibroblast growth factor-20 protects against dopamine neuron loss in vitro and provides functional protection in the 6-hydroxydopamine-lesioned rat model of Parkinson's disease.
    Sleeman IJ; Boshoff EL; Duty S
    Neuropharmacology; 2012 Dec; 63(7):1268-77. PubMed ID: 22971544
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of Aging on the 6-OHDA-Induced Rat Model of Parkinson's Disease.
    Barata-Antunes S; Teixeira FG; Mendes-Pinheiro B; Domingues AV; Vilaça-Faria H; Marote A; Silva D; Sousa RA; Salgado AJ
    Int J Mol Sci; 2020 May; 21(10):. PubMed ID: 32422916
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Neuroprotective Effects of the CB2 Agonist GW842166x in the 6-OHDA Mouse Model of Parkinson's Disease.
    Yu H; Liu X; Chen B; Vickstrom CR; Friedman V; Kelly TJ; Bai X; Zhao L; Hillard CJ; Liu QS
    Cells; 2021 Dec; 10(12):. PubMed ID: 34944056
    [TBL] [Abstract][Full Text] [Related]  

  • 9. α4 nicotinic acetylcholine receptor modulated by galantamine on nigrostriatal terminals regulates dopamine receptor-mediated rotational behavior.
    Inden M; Takata K; Yanagisawa D; Ashihara E; Tooyama I; Shimohama S; Kitamura Y
    Neurochem Int; 2016 Mar; 94():74-81. PubMed ID: 26911419
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Auricular Vagus Nerve Stimulation Exerts Antiinflammatory Effects and Immune Regulatory Function in a 6-OHDA Model of Parkinson's Disease.
    Jiang Y; Cao Z; Ma H; Wang G; Wang X; Wang Z; Yang Y; Zhao H; Liu G; Li L; Feng T
    Neurochem Res; 2018 Nov; 43(11):2155-2164. PubMed ID: 30311182
    [TBL] [Abstract][Full Text] [Related]  

  • 11. α7 nicotinic acetylcholine receptor mediated neuroprotection in Parkinson's disease.
    Kawamata J; Suzuki S; Shimohama S
    Curr Drug Targets; 2012 May; 13(5):623-30. PubMed ID: 22300030
    [TBL] [Abstract][Full Text] [Related]  

  • 12. α7 nicotinic acetylcholine receptor-mediated neuroprotection against dopaminergic neuron loss in an MPTP mouse model via inhibition of astrocyte activation.
    Liu Y; Hu J; Wu J; Zhu C; Hui Y; Han Y; Huang Z; Ellsworth K; Fan W
    J Neuroinflammation; 2012 May; 9():98. PubMed ID: 22624500
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acetyl-l-carnitine protects dopaminergic nigrostriatal pathway in 6-hydroxydopamine-induced model of Parkinson's disease in the rat.
    Afshin-Majd S; Bashiri K; Kiasalari Z; Baluchnejadmojarad T; Sedaghat R; Roghani M
    Biomed Pharmacother; 2017 May; 89():1-9. PubMed ID: 28199883
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activin A protects midbrain neurons in the 6-hydroxydopamine mouse model of Parkinson's disease.
    Stayte S; Rentsch P; Li KM; Vissel B
    PLoS One; 2015; 10(4):e0124325. PubMed ID: 25902062
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acupuncture prevents 6-hydroxydopamine-induced neuronal death in the nigrostriatal dopaminergic system in the rat Parkinson's disease model.
    Park HJ; Lim S; Joo WS; Yin CS; Lee HS; Lee HJ; Seo JC; Leem K; Son YS; Kim YJ; Kim CJ; Kim YS; Chung JH
    Exp Neurol; 2003 Mar; 180(1):93-8. PubMed ID: 12668152
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Riluzole neuroprotection in a Parkinson's disease model involves suppression of reactive astrocytosis but not GLT-1 regulation.
    Carbone M; Duty S; Rattray M
    BMC Neurosci; 2012 Apr; 13():38. PubMed ID: 22480308
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuroprotective effects of garlic extract on dopaminergic neurons of substantia nigra in a rat model of Parkinson's disease: motor and non-motor outcomes.
    Bigham M; Mohammadipour A; Hosseini M; Malvandi AM; Ebrahimzadeh-Bideskan A
    Metab Brain Dis; 2021 Jun; 36(5):927-937. PubMed ID: 33656625
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Propolis as A Potential Disease-Modifying Strategy in Parkinson's Disease: Cardioprotective and Neuroprotective Effects in the 6-OHDA Rat Model.
    Gonçalves VC; Pinheiro DJLL; de la Rosa T; de Almeida AG; Scorza FA; Scorza CA
    Nutrients; 2020 May; 12(6):. PubMed ID: 32466610
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuroprotective Activities of Curcumin in Parkinson's Disease: A Review of the Literature.
    Nebrisi EE
    Int J Mol Sci; 2021 Oct; 22(20):. PubMed ID: 34681908
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Brain α7 nicotinic acetylcholine receptors in MPTP-lesioned monkeys and parkinsonian patients.
    Morissette M; Morin N; Grégoire L; Rajput A; Rajput AH; Di Paolo T
    Biochem Pharmacol; 2016 Jun; 109():62-69. PubMed ID: 27038656
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.